Siblings 會議論文/會議摘要 [0/3] Collection Statistics 近3年內發表的文件:4(21.05%) 含全文筆數:19(100.00%) 文件下載次數統計 下載大於0次:19(100.00%) 下載大於100次:18(94.74%) 檔案下載總次數:12514(100.00%) 最後更新時間: 2024-12-01 07:41 Top Upload Loading... Top Download Loading... Recent Submissions Immunotherapeutic IL-6R and targeti... Sequence-specific targeting of C. e... Oligo-fucoidan supplementation enha... Targeting prooxidant MnSOD effect i... Oligo-fucoidan prevents M2 macropha... MCT-1/miR-34a/IL-6/IL-6R signaling ... Oligo-Fucoidan prevents IL-6 and CC... Oncogenic MCT-1 activation promotes... MCT-1 expression and PTEN deficienc... Targeting MCT-1 oncogene inhibits S...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-19 of 19. (1 Page(s) Totally) 1  View [10|25|50] records per page

Date	Title	Relation
2024-03-03	Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1 circuit prevent relapse and metastasis of triple-negative breast cancer	Theranostics. 2024 Mar 03;14(5):2167-2189.
2023-08-09	Sequence-specific targeting of C. elegans C-Ala to the D-loop of tRNA(Ala)	Journal of Biological Chemistry. 2023 Aug 9;299-302(9):Article number 105149.
2022-09-15	Oligo-fucoidan supplementation enhances the effect of olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice	Journal of Biomedical Science. 2022 Sep 15;29:Article number 70.
2022-01-11	Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress	Cell Death and Disease. 2022 Jan 11;13:Article number 49.
2020-02-12	Oligo-fucoidan prevents M2 macrophage differentiation and HCT116 tumor progression	Cancers. 2020 Feb 12;12(2):Article number 421.
2019-03-18	MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer	Molecular Cancer. 2019 Mar 18(1);18:Article number 42.
2017-09-19	Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression	Scientific Reports. 2017 Sep 19;7:Article number 11864.
2017-04-10	Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression	Oncogenesis. 2017 Apr 10;6(4):Article number e313.
2014-10	MCT-1 expression and PTEN deficiency synergistically promote neoplastic multinucleation through the Src/p190B signaling activation	Oncogene. 2014 Oct;33(44):5109-5120.
2012-11	Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity	Oncotarget. 2012 Nov;3(11):1401-1415.
2012-04	Interplay between cell migration and neurite outgrowth eetermines SH2B1Beta-enhanced neurite regeneration of differentiated PC12 cells	PLoS ONE. 2012 Apr;7(4):Article number e34999.
2012-03-01	The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities	Cell Cycle. 2012 Mar 1;11(5):934-952.
2010-12	The antagonism between MCT-1 and p53 affects the tumorigenic outcomes	Molecular Cancer. 2010 Dec;9:Article number 311.
2010-09-27	The adaptor protein SH2B1Beta reduces hydrogen peroxide-induced cell death in PC12 cells and hippocampal neurons	Journal of Molecular Signaling. 2010 Sep;5:Article number 17.
2009-04	Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity	Molecular Cancer Research. 2009 Apr;7(4):536-548.
2007-09-01	MCT-1 oncogene downregulates p53 and destabilizes genome structure in the response to DNA double-strand damage	DNA Repair. 2007 Sep;6(9):1319-1332.
2007-09	Apoptotic cleavage of NuMA at the C-terminal end is related to nuclear disruption and death amplification	Journal of Biomedical Science. 2007 Sep;14(5):681-694.
2007-04-19	Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damage [Erratum: Oncogene. 2007 Apr;26(16):2283-2289.]	Oncogene. 2007 Apr;26(18):2674-2674.
2005-07	The MCT-1 oncogene product impairs cell cycle checkpoint control and transforms human mammary epithelial cells	Oncogene. 2005 Jul;24(31):4956-4964.

Showing items 1-19 of 19. (1 Page(s) Totally) 1  View [10|25|50] records per page